Literature DB >> 19008299

Cerebrocostomandibular-like syndrome and a mutation in the conserved oligomeric Golgi complex, subunit 1.

Renate Zeevaert1, François Foulquier, Boyan Dimitrov, Ellen Reynders, Rita Van Damme-Lombaerts, Emil Simeonov, Wim Annaert, Gert Matthijs, Jaak Jaeken.   

Abstract

We describe two patients with a cerebrocostomandibular-like syndrome and a novel mutation in conserved oligomeric Golgi (COG) subunit 1, one of the subunits of the conserved oligomeric Golgi complex. This hetero-octameric protein complex is involved in retrograde vesicular trafficking and glycosylation. We identified in both patients an intronic mutation, c.1070+5G>A, that disrupts a splice donor site and leads to skipping of exon 6, a frameshift and a premature stopcodon in exon 7. Real-time reverse transcriptase polymerase chain reaction showed in the first patient only 3% of normal transcript when compared with control. A delay in retrograde trafficking could be demonstrated by Brefeldin A treatment of this patient's fibroblasts. The costovertebral dysplasia of the two patients has been described in cerebrocostomandibular syndrome (CCMS), but also in cerebrofaciothoracic dysplasia and spondylocostal dysostosis. CCMS itself is heterogeneous because both autosomal dominant and autosomal recessive inheritance has been described. We anticipate further genetic heterogeneity because no mutations in COG1 were found in two additional patients with a CCMS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19008299     DOI: 10.1093/hmg/ddn379

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  13 in total

1.  Conserved oligomeric Golgi complex specifically regulates the maintenance of Golgi glycosylation machinery.

Authors:  Irina D Pokrovskaya; Rose Willett; Richard D Smith; Willy Morelle; Tetyana Kudlyk; Vladimir V Lupashin
Journal:  Glycobiology       Date:  2011-03-18       Impact factor: 4.313

2.  COG5-CDG with a Mild Neurohepatic Presentation.

Authors:  C W Fung; G Matthijs; L Sturiale; D Garozzo; K Y Wong; R Wong; V Wong; J Jaeken
Journal:  JIMD Rep       Date:  2011-09-22

3.  Bone Dysplasia as a Key Feature in Three Patients with a Novel Congenital Disorder of Glycosylation (CDG) Type II Due to a Deep Intronic Splice Mutation in TMEM165.

Authors:  R Zeevaert; F de Zegher; L Sturiale; D Garozzo; M Smet; M Moens; G Matthijs; J Jaeken
Journal:  JIMD Rep       Date:  2012-08-22

Review 4.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2014-05-26       Impact factor: 10.946

Review 5.  Golgi glycosylation and human inherited diseases.

Authors:  Hudson H Freeze; Bobby G Ng
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-09-01       Impact factor: 10.005

6.  Comparative analyses of the Conserved Oligomeric Golgi (COG) complex in vertebrates.

Authors:  Rita Quental; Luísa Azevedo; Rune Matthiesen; António Amorim
Journal:  BMC Evol Biol       Date:  2010-07-15       Impact factor: 3.260

Review 7.  Glycosylation disorders of membrane trafficking.

Authors:  Claire Rosnoblet; Romain Peanne; Dominique Legrand; François Foulquier
Journal:  Glycoconj J       Date:  2012-05-15       Impact factor: 2.916

Review 8.  Congenital disorders of glycosylation: new defects and still counting.

Authors:  Kyle Scott; Therese Gadomski; Tamas Kozicz; Eva Morava
Journal:  J Inherit Metab Dis       Date:  2014-05-15       Impact factor: 4.982

9.  Golgi function and dysfunction in the first COG4-deficient CDG type II patient.

Authors:  Ellen Reynders; François Foulquier; Elisa Leão Teles; Dulce Quelhas; Willy Morelle; Cathérine Rabouille; Wim Annaert; Gert Matthijs
Journal:  Hum Mol Genet       Date:  2009-06-03       Impact factor: 6.150

10.  COG5-CDG: expanding the clinical spectrum.

Authors:  Daisy Rymen; Liesbeth Keldermans; Valérie Race; Luc Régal; Nicolas Deconinck; Carlo Dionisi-Vici; Cheuk-Wing Fung; Luisa Sturiale; Claire Rosnoblet; François Foulquier; Gert Matthijs; Jaak Jaeken
Journal:  Orphanet J Rare Dis       Date:  2012-12-10       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.